Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma

Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma Molecular Therapy 24, 1602 (september 2016). doi:10.1038/mt.2016.146 Authors: M Kazim Panjwani, Jenessa B Smith, Keith Schutsky, Josephine Gnanandarajah, Colleen M O’Connor, Daniel J Powell & Nicola J Mason

http://feeds.nature.com/~r/mt/rss/current/~3/rUwF88kZgwo/mt.2016.146

Source: Molecular Therapy - September 28, 2016 Category: Genetics & Stem Cells Authors: M Kazim Panjwani Jenessa B Smith Keith Schutsky Josephine Gnanandarajah Colleen M O ’Connor Daniel J Powell Nicola J Mason Source Type: research

More News: Lymphoma